Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy.
Jiang X, Wang J, Zheng X, Liu Z, Zhang X, Li Y, Wilhelm J, Cao J, Huang G, Zhang J, Sumer B, Lea J, Lu Z, Gao J, Luo M.
Jiang X, et al.
J Immunother Cancer. 2022 May;10(5):e003960. doi: 10.1136/jitc-2021-003960.
J Immunother Cancer. 2022.
PMID: 35623658
Free PMC article.